Page 9 - GP Spring 2022
P. 9

nicians that feel confident enough in their   12. Becker DE. Cardiovascular drugs:      Ricardo Ivan Carreon
        skillset  to  deal  with  potential  complica-  implications  for dental  practice  part  1   is a student at NYU
        tions  and  have  the  willingness  to  invest   -  cardiotonics,  diuretics,  and  vasodila-  College of Dentistry in
        the time necessary to develop a strong re-  tors.  Anesth  Prog.  2007;54(4):178-187.   the class of 2022.
        lationship, which can vastly improve pa-  doi:10.2344/0003-3006(2007)54[178:CDIFD-
                                             P]2.0.CO;2
        tient outcomes. This is unfortunately much   13. Becker D.E, Reed  K.L. Essentials  of lo-
        more  difficult  to  find  in  dentistry  than  it   cal anesthetic  pharmacology.  Anesth Prog.
        should  be.  Despite  multiple  potential  ar-  2006;53(3):98–108.
        eas for complications, none were encoun-  14. Prasanthi B, Kannan N, Patil R. Effect of
        tered during treatment. A strong emphasis   Diuretics on Salivary Flow, Composition and   Juhee Kim is a student at
        was placed on following recommendations   Oral Health  Status: A Clinico-biochemical    NYU College of Dentist-
        from the American Heart Association and   Study. Ann Med Health Sci Res. 2014;4(4):549-  ry in the class of 2023.
        on communicating with the patient’s med-  553. doi:10.4103/2141-9248.139311.
        ical  management  team.  Greater  clinician   15.  Villa  A, Connell  CL,  Abati  S.  Diagnosis
        education is recommended so that patients   and management  of xerostomia and hyposali-
                                             vation. Ther Clin Risk Manag. 2014;11:45-51.
        with complex conditions that are manage-  Published 2014 Dec 22. doi:10.2147/TCRM.
        able in a dental office setting can receive   S76282.
        routine care without having to resort to a   16. Fisher BJ, Spencer A, Haywood V, Kon-
        hospital setting.                    chady G. Relieving Dry Mouth: Varying Levels       Angela De Bartolo, DDS,
                                             of pH Found in Bottled Water. Compend Contin       is a Clinical Associate
        References                           Educ Dent. 2017;38(7):e17-e20.                     Professor at NYU Col-
        1. Parmley W. W. Pathophysiology of con-  17. Boskabady M, Nematollahi H, Boskabady     lege of Dentistry in the
        gestive heart failure. The American journal of   MH. Effect of inhaled medication and inhalation
        cardiology.  1985;56(2),  7A–11A. https://doi.  technique on dental caries in asthmatic patients.   Department of  Cariolo-
        org/10.1016/0002-9149(85)91199-3.    Iran Red Crescent Med J. 2012;14(12):816-821.      gy and Comprehensive
        2. Skrzypek, A., Mostowik,  M., Szeliga,  M.,   doi:10.5812/ircmj.4658.                 Care and she is a Group
        Wilczyńska-Golonka,  M.,  Dębicka-Dąbrows-  18. Guimaraes  CC, Lopes  LC, Bergamaschi   Practice Director.
        ka, D., & Nessler, J. Chronic heart failure in the   CC, et al. Local  anaesthetics  combined  with
        elderly:  still  a current  medical problem. Folia   vasoconstrictors  in  patients  with  cardiovascu-  Analia Veitz-Keenan, DDS
        medica Cracoviensia. 2018;58(4), 47–56.  lar disease undergoing dental procedures: sys-  is a Clinical Professor at
        3. Bui, A. L., Horwich, T. B., Fonarow, G. C.   tematic review and meta-analysis. BMJ Open.
        Epidemiology and risk profile of heart failure.   2021;11(7):e044357. Published 2021 Jul 15.   the NYU College of Den-
        Nature reviews, Cardiology. 2011;8(1), 30–41.   doi:10.1136/bmjopen-2020-044357.        tistry Department Oral
        https://doi.org/10.1038/nrcardio.2010.165.  19. Schaefer JK, Li Y, Gu X, et al. Associa-  Maxillofacial Pathology,
        4.  Frolova  E.  V. Kardiologiia,  58(Suppl  8),   tion  of Adding Aspirin to  Warfarin Therapy   Radiology and Medicine
        4–11. 2018.                          Without an Apparent Indication With Bleeding       and  Epidemiology  and
        5. Di Palo, K. E., Barone, N. J. Hypertension   and Other Adverse Events. JAMA Intern Med.   Health Promotion and the
        and Heart Failure: Prevention, Targets, and   2019; 179(4):533–541. doi:10.1001/jamaint-  NYAGD President-Elect.
        Treatment. Heart failure  clinics. 2020;16(1),   ernmed.2018.7816.
        99–106.                              20. Jack Hirsh, MD, FRCP(C), FRACP, FRSC,
        https://doi.org/10.1016/j.hfc.2019.09.001.  DSc  ,  Valentin  Fuster,  MD, PhD  ,  Jack  An-
        6. Yancy CW, Januzzi JL Jr, Allen LA, et al.   sell,  MD  , and  Jonathan  L.  Halperin,  MD.
        2017 ACC Expert Consensus Decision Pathway   American Heart Association/American College
        for Optimization  of Heart Failure Treatment:   of Cardiology  Foundation  Guide  to  Warfarin
        Answers to 10 Pivotal Issues About Heart Fail-  Therapy.Circulation,2003;107 (12) 1692-1711.
        ure With Reduced Ejection Fraction: A Report   21. Olin B.R, Hebel S.K, Dombek C.E, editors.
        of the  American  College  of Cardiology  Task   Drug Interaction Facts. St Louis, Mo: Facts and
        Force on Expert Consensus Decision Pathways.   Comparisons Inc; 2007.
        J Am Coll Cardiol 2018; 71:201.      22. Madhero88, CC BY-SA 3.0 <https://cre-
        7. Gustafsson, F., & Rogers, J. G. Left ventricu-  ativecommons.org/licenses/by-sa/3.0>, via
        lar assist device therapy in advanced heart fail-  Wikimedia Commons
        ure: patient selection and outcomes. European
        journal of heart failure. 2017;19(5), 595–602.
        https://doi.org/10.1002/ejhf.779.
        8. Smith EM, Franzwa J. Chronic outpatient man-
        agement of patients with a left ventricular assist
        device.  J Thorac Dis.  2015;7(12):2112-2124.
        doi:10.3978/j.issn.2072-1439.2015.10.28.
        9. https://www.nursingcenter.com/ncblog/decem-
        ber-2011/calculating-the-map. Last accessed Dec
        2021.
        10. Wilson WR, Gewitz M, Lockhart PB, et al.
        Prevention of Viridans Group Streptococcal
        Infective  Endocarditis:  A  Scientific  Statement
        From the American Heart Association. Circula-
        tion. 2021:Cir0000000000000969.
        11. Lockhart PB, Brennan MT, Thornhill M, et
        al. Poor oral hygiene as a risk factor for infec-
        tive endocarditis-related bacteremia. J Am Dent
        Assoc. 2009;140(10):1238-1244. doi:10.14219/
        jada.archive.2009.0046.                                                      www.nysagd.org l Spring 2022 l GP 9
   4   5   6   7   8   9   10   11   12   13   14